ArticleEuropean journal of nuclear medicine and molecular imaging2026

Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy.

Emilio Francesco Giunta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.